PRESS RELEASE
8 June 2026

Mintz Advising on $215 Million Private Placement Concurrent with Avenzo Therapeutics’ and Rallybio’s Merger Transaction

M
Mintz

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
Mintz is advising the placement agents in connection with the $215 million private placement that is expected to close concurrently with the completion of the merger transaction...
United States

Mintz is advising the placement agents in connection with the $215 million private placement that is expected to close concurrently with the completion of the merger transaction between Avenzo Therapeutics, Inc. and Rallybio Corporation.

Leerink Partners, Goldman Sachs & Co. LLC, Piper Sandler, and Guggenheim Securities are acting as placement agents in connection with the private placement.

The Mintz capital markets team includes William Hicks, John Rudy, Alok Choksi, Gianna Nappi, Jocelyn Sun, and Kate McLeod. Joanne Hawana is advising on regulatory matters, and Ed Koundakjian is advising on intellectual property matters. Members of the Mintz team are based in the Boston, New York, San Diego and Washington, DC offices.

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More